“Preclinical efficacy and cellular mechanisms of a polyherbal formulation in doxorubicin nephrotoxicity: PRECLINICAL SAFETY AND EFFICACY OF A POLYHERBAL FORMULATION”, IJTK, vol. 24, no. 1, pp. 33–41, Jan. 2025, doi: 10.56042/ijtk.v24i1.5664.